Quote | Roivant Sciences Ltd. (NASDAQ:ROIV)
Last: | $10.46 |
---|---|
Change Percent: | 0.58% |
Open: | $10.3 |
Close: | $10.46 |
High: | $10.48 |
Low: | $10.265 |
Volume: | 4,662,616 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Roivant Sciences Ltd. (NASDAQ:ROIV)
2024-04-14 09:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-10 04:22:17 ET Summary Arbutus Biopharma and Roivant won a crucial claims construction ruling in their patent infringement lawsuit against Moderna. The ruling opens the way for a potential total win against Moderna, but uncertainties remain regarding the lawsuit and Arbutu...
Message Board Posts | Roivant Sciences Ltd. (NASDAQ:ROIV)
Subject | By | Source | When |
---|---|---|---|
Vivek is going postal on ESG. | TooFrank | investorshub | 05/13/2022 4:32:37 AM |
MERRY CHRISTMAS , Roivant Sciences Ltd ($ROIV) | mick | investorshub | 12/24/2021 1:06:12 AM |
$ROIV progressing nicely since that initial dip to $6. | aries4747 | investorshub | 12/23/2021 11:24:45 PM |
Roivant Sciences Ltd ($ROIV) | mick | investorshub | 12/20/2021 8:47:42 PM |
https://www.otcmarkets.com/stock/$ROIV/disclosure | mick | investorshub | 12/20/2021 6:28:28 PM |
News, Short Squeeze, Breakout and More Instantly...
Roivant Sciences Ltd. Company Name:
ROIV Stock Symbol:
NASDAQ Market:
2024-04-14 09:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-02 17:15:03 ET Goldman Sachs analyst issues BUY recommendation for ROIV on April 2, 2024 03:55PM ET. The previous analyst recommendation was Buy. ROIV was trading at $10.92 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current a...
2024-04-02 17:00:03 ET Corinne Jenkins from Goldman Sachs issued a price target of $18.00 for ROIV on 2024-04-02 15:55:00. The adjusted price target was set to $18.00. At the time of the announcement, ROIV was trading at $10.92. The overall price target consensus is at $...